glp-1 heart disease Frontiers The FDA has approved a

Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027

Compare 2026 Ozempic, Wegovy, Rybelsus and generic semaglutide costs, insurance and safe buying.

Purpose of Review Obesity affects over than 600 million adults worldwide resulting in multi-organ complications and major socioeconomic impact

Ordering Information Target Catalog No

Download our complete GLP-1 microdosing guide with age-specific dosing strategies, aesthetic support treatments, and nutrient protocols for safe, effective weight loss.

The GLP-1 effect isnt just a trend, its a structural shift in how people approach their bodies and their aesthetic goals